Yale Cancer Center Study Shows New Treatment Pathway to Prevent and Treat Endometrial Cancer Recurrence
February 24, 2021
February 24, 2021
NEW HAVEN, Connecticut, Feb. 24 (TNSJou) -- Yale School of Medicine issued the following news on Feb. 23, 2021:
In a new study led by Yale Cancer Center, researchers demonstrate sex hormones and insulin growth factors are associated with recurrence risk of endometrial cancer. The findings suggest endocrine-targeted therapies and an assessment of biomarkers in hormone and insulin signaling pathways may be useful in the prevention and treatment of endometrial cancer recurrence. The st . . .
In a new study led by Yale Cancer Center, researchers demonstrate sex hormones and insulin growth factors are associated with recurrence risk of endometrial cancer. The findings suggest endocrine-targeted therapies and an assessment of biomarkers in hormone and insulin signaling pathways may be useful in the prevention and treatment of endometrial cancer recurrence. The st . . .